[ad_1] Roth starts CG Oncology at purchase, cites anticipated FDA filing [ad_2] Source: Seekingalpha
Browsing: buy
[ad_1] narvikk PTC Therapeutics (NASDAQ:PTCT) is up ~2% in Monday buying and selling after UBS resumed coverage of the inventory with a buy rating. The agency…
[ad_1] peterschreiber.media BofA began protection of Biohaven (NYSE:BHVN) with a purchase ranking, citing its drug improvement applications for temper and autoimmune problems. The funding financial institution…
[ad_1] HJBC Accenture (NYSE:ACN) has agreed to purchase consus.well being, a German healthcare administration consultancy, expanding its capabilities in the nation. consus.well being provides companies starting…
[ad_1] narvikk PTC Therapeutics (NASDAQ:PTCT) is up ~2% in Monday buying and selling after UBS resumed coverage of the inventory with a buy rating. The agency…
[ad_1] peterschreiber.media BofA began protection of Biohaven (NYSE:BHVN) with a purchase ranking, citing its drug improvement applications for temper and autoimmune issues. The funding financial institution…
[ad_1] HJBC Accenture (NYSE:ACN) has agreed to purchase consus.well being, a German healthcare administration consultancy, expanding its capabilities in the nation. consus.well being gives providers starting…
[ad_1] narvikk PTC Therapeutics (NASDAQ:PTCT) is up ~2% in Monday buying and selling after UBS resumed coverage of the inventory with a buy rating. The agency…
[ad_1] peterschreiber.media BofA began protection of Biohaven (NYSE:BHVN) with a purchase score, citing its drug improvement packages for temper and autoimmune problems. The funding financial institution…
[ad_1] narvikk PTC Therapeutics (NASDAQ:PTCT) is up ~2% in Monday buying and selling after UBS resumed coverage of the inventory with a buy rating. The agency…